About us
ORION-4 has been designed and is coordinated by Oxford University’s Clinical Trial Service Unit (CTSU) (part of the Nuffield Department of Population Health), one of the world’s leading centres for this type of research.
The study is co-sponsored by the University of Oxford and Novartis Pharmaceutical Corporation and is designed and run in collaboration with researchers at the TIMI Study Group at Brigham and Women’s Hospital in Boston, USA.
See Our Team for more information about the people leading and running the study at CTSU.